Transcription factor Nrf2 activation regulates NETosis, endothelial injury, and kidney disease in myeloperoxidase-positive antineutrophil cytoplasmic antibody-associated vasculitis
Kidney International · 2024-06 · 105 (6) · 1291-1305
DOI: 10.1016/j.kint.2024.03.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney International, 2024-06. Verfasst von Yusho Ueda und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Endocrinology, and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Extracellular Traps, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Neutrophils. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Government of Japan Ministry of Education Culture Sports Science and Technology.
Abstract (Originalsprache)
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a systemic autoimmune disease pathologically characterized by vascular necrosis with inflammation. During AAV development, activated neutrophils produce reactive oxygen species (ROS), leading to the aberrant formation of neutrophil extracellular traps (NETs) via NETosis and subsequent fibrinoid vascular necrosis. Nuclear factor-erythroid 2-related factor 2 (Nrf2) functions as an intracellular defense system to counteract oxidative stress by providing antioxidant properties. Herein, we explored the role of Nrf2 in the pathogenesis of AAV. The role and mechanism of Nrf2 in ANCA-stimulated neutrophils and subsequent endothelial injury were evaluated in vitro using Nrf2 genetic deletion and Nrf2 activator treatment. In corresponding in vivo studies, the role of Nrf2 in ANCA-transfer AAV and spontaneous AAV murine models was examined. Pharmacological activation of Nrf2 in vitro suppressed ANCA-induced NET formation via the inhibition of ROS. In contrast, NET formation was enhanced in Nrf2-deficient neutrophils. Furthermore, Nrf2 activation protected endothelial cells from ANC-induced NETs-mediated injury. In vivo, Nrf2 activation ameliorated glomerulonephritis in two AAV models by upregulating antioxidants and inhibiting ROS-mediated NETs. Furthermore, Nrf2 activation restrained the expansion of splenic immune cells, including T lymphocytes and limited the infiltration of Th17 cells into the kidney. In contrast, Nrf2 genetic deficiency exacerbated vasculitis in a spontaneous AAV model. Thus, the pathophysiological process in AAV may be downregulated by Nrf2 activation, potentially leading to a new therapeutic strategy by regulating NETosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Endocrinology, and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
- Department of Rheumatology, Endocrinology, and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan. Electronic address: daigo-na@med.hokudai.ac.jp.
- Department of Pathology, Sapporo City General Hospital, Sapporo, Japan.
- Department of Surgical Pathology, Hokkaido University Hospital, Sapporo, Japan.
- Graduate School of Nanobioscience, Yokohama City University, Yokohama, Japan.
- Department of Medical Laboratory Science, Faculty of Health Sciences, Hokkaido University, Sapporo, Japan.
Förderung
- Government of Japan Ministry of Education Culture Sports Science and Technology
Zitieren
APA
Ueda, Y., Nakazawa, D., Nishio, S., Shiratori-Aso, S., Kudo, T., Miyoshi-Harashima, A., Watanabe-Kusunoki, K., Hattanda, F., Iwasaki, S., Tsuji, T., Tomaru, U., Aratani, Y., Yamamoto, M., Ishizu, A., & Atsumi, T. (2024). Transcription factor Nrf2 activation regulates NETosis, endothelial injury, and kidney disease in myeloperoxidase-positive antineutrophil cytoplasmic antibody-associated vasculitis. Kidney International, 105(6), 1291-1305. https://doi.org/10.1016/j.kint.2024.03.010
Vancouver
Ueda Y, Nakazawa D, Nishio S, Shiratori-Aso S, Kudo T, Miyoshi-Harashima A, et al. Transcription factor Nrf2 activation regulates NETosis, endothelial injury, and kidney disease in myeloperoxidase-positive antineutrophil cytoplasmic antibody-associated vasculitis. Kidney International. 2024;105(6):1291-1305. doi:10.1016/j.kint.2024.03.010
BibTeX
@article{Ueda2024,
author = {Ueda, Yusho and Nakazawa, Daigo and Nishio, Saori and Shiratori-Aso, Satoka and Kudo, Takashi and Miyoshi-Harashima, Atsuko and Watanabe-Kusunoki, Kanako and Hattanda, Fumihiko and Iwasaki, Sari and Tsuji, Takahiro and Tomaru, Utano and Aratani, Yasuaki and Yamamoto, Mamiko and Ishizu, Akihiro and Atsumi, Tatsuya},
title = {Transcription factor Nrf2 activation regulates NETosis, endothelial injury, and kidney disease in myeloperoxidase-positive antineutrophil cytoplasmic antibody-associated vasculitis},
journal = {Kidney International},
year = {2024},
volume = {105},
number = {6},
pages = {1291--1305},
doi = {10.1016/j.kint.2024.03.010}
}
EUVIMED